Delivery Order SPE2DB22D1106-SPE2DB25FFHT4
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,194.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 30 mg/ml vials. The contract is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency has awarded a delivery order valued at $2,909.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitive award, issued on August 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.96 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This contract, awarded on August 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ketorolac 30 mg/mL vials valued at $1,298.52. This award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. As a child...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ketorolac 30 mg/ml vials with a ceiling value of $1,382.72. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This award represents...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ketorolac 10 mg tablets (100-count units) with a ceiling value of $1,985.20. The contract is a non-set-aside award performed at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of September 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for the supply of Ketorolac 30 mg/ml vials. The contract, issued on August 8, 2025, carries a ceiling value of $1,279.84 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,241.06 to AmerisourceBergen Drug Corp for Ketorolac 60 mg/2 mL vials on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed-price contract, classified as a non-set-aside award, represents a competitive procurement of pharmaceutical pain management medication to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vials with a ceiling value of $2,144.62 under a firm fixed-price contract awarded on August 21, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's broader relationship with the federal government's medical procurement systems. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHT4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ketorolac 30 mg/ml vials under a firm fixed-price contract with a ceiling value of $2,695.94. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceuticals and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company holds extensive federal contract awards with the Defense Logistics Agency and its Medical Supply Chain, demonstrating capability to fulfill diverse medical procurement requirements through open competition. The Ketorolac delivery represents part of the company's ongoing role in supplying pain management pharmaceuticals and other critical medications across multiple therapeutic domains to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/9/25 |